BOXED WARNING NSAID: serious cardiovascular thrombotic events (MI, stroke) and serious GI bleeding/ulceration/perforation; contraindicated for CABG surgery
FDA dosing
Population
Start
Target
Max
Rheumatoid arthritis / osteoarthritis
adult
75 mg TID or 50 mg QID
300 mg/day
Mild-to-moderate pain and dysmenorrhea
adult
25-50 mg q6-8h PRN
doses >75 mg give no added analgesia; ≤300 mg/day
Renal Mild impairment: max 150 mg/day. Severe (GFR <25 mL/min/1.73m² or ESRD): max 100 mg/day
Hepatic Impaired liver function with albumin <3.5 g/dL: max initial 100 mg/day
Instructions
Use lowest effective dose for shortest duration
May take with antacids, food, or milk to reduce GI effects
Reduce initial dosage in patients over 75 yr
Contraindications
Asthma, urticaria, or allergic-type reactions after aspirin or other NSAIDs
Coronary artery bypass graft (CABG) surgery
Cautions
Cardiovascular thrombotic events
GI bleeding, ulceration, perforation
Hepatotoxicity
Hypertension, heart failure/edema
Renal toxicity
Anaphylactoid reactions
Serious skin reactions
Adverse reactions
Dyspepsia and other GI symptoms (nausea, abdominal pain, diarrhea, constipation, flatulence)
Peptic ulcer/GI bleeding
Headache
Fluid retention
Pregnancy Avoid at ~30 weeks gestation and later (premature ductus arteriosus closure); limit use 20-30 weeks (oligohydramnios/neonatal renal impairment)
Lactation Undefined
⚠ BOXED WARNINGS
Cardiovascular thrombotic events
Gastrointestinal bleeding, ulceration and perforation